Table 3 Correlation between CDH3 expression and drug sensitivity
From: Synergistic potential of CDH3 in targeting CRC metastasis and enhancing immunotherapy
symbol | drug | correlation | FDR |
|---|---|---|---|
CDH3 | Afatinib | -0.433009802 | 1.59175E-42 |
CDH3 | Gefitinib | -0.423051364 | 3.08454E-35 |
CDH3 | Lapatinib | -0.384174618 | 6.7966E-13 |
CDH3 | Erlotinib | -0.354267328 | 9.39737E-10 |
CDH3 | WZ-1-84 | -0.296077215 | 1.10929E-06 |
CDH3 | I-BET-762 | 0.265982546 | 1.89529E-15 |
CDH3 | CAY10603 | 0.259501778 | 1.99245E-14 |
CDH3 | UNC0638 | 0.255066144 | 1.10165E-14 |
CDH3 | Cetuximab | -0.254563214 | 3.46088E-12 |
CDH3 | JW-7-24-1 | 0.252319155 | 9.49013E-14 |
CDH3 | QL-XI-92 | 0.249700578 | 2.30795E-13 |
CDH3 | TG101348 | 0.2468639 | 3.26258E-13 |
CDH3 | TL-1-85 | 0.245228778 | 5.92687E-13 |
CDH3 | CEP-701 | 0.240245129 | 4.98804E-11 |
CDH3 | FK866 | 0.239090273 | 3.67029E-12 |
CDH3 | BX-912 | 0.235503997 | 3.60883E-12 |
CDH3 | THZ-2-49 | 0.232899603 | 2.13678E-11 |
CDH3 | Y-39,983 | 0.229165486 | 4.23549E-11 |
CDH3 | AR-42 | 0.228503845 | 2.71926E-11 |
CDH3 | PIK-93 | 0.225767597 | 2.79669E-11 |
CDH3 | Tubastatin A | 0.224910368 | 4.46462E-11 |
CDH3 | KIN001-260 | 0.223911482 | 7.51514E-11 |
CDH3 | NG-25 | 0.223622644 | 5.93088E-11 |
CDH3 | Nutlin-3a (-) | 0.222378533 | 1.28988E-08 |
CDH3 | Vorinostat | 0.221326615 | 4.23034E-10 |
CDH3 | NPK76-II-72-1 | 0.220386701 | 7.09517E-11 |
CDH3 | Navitoclax | 0.22016195 | 5.82113E-10 |
CDH3 | GSK429286A | 0.214582621 | 2.92726E-09 |
CDH3 | TPCA-1 | 0.213691724 | 3.38968E-10 |
CDH3 | OSI-027 | 0.212509268 | 7.64225E-10 |